S 1352 ISCommentsClose CommentsPermalink

To provide for the expansion of Federal efforts concerning the prevention, education, treatment, and research activities related to Lyme and other tick-borne diseases, including the establishment of a Tick-Borne Diseases Advisory Committee.CommentsClose CommentsPermalink

June 25, 2009CommentsClose CommentsPermalink

Mr. DODD (for himself, Ms. COLLINS, Mr. REED, Mr. LIEBERMAN, Mr. CARDIN, and Mr. WHITEHOUSE) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and PensionsCommentsClose CommentsPermalink

To provide for the expansion of Federal efforts concerning the prevention, education, treatment, and research activities related to Lyme and other tick-borne diseases, including the establishment of a Tick-Borne Diseases Advisory Committee.CommentsClose CommentsPermalink

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,CommentsClose CommentsPermalink

SECTION 1. SHORT TITLE.

This Act may be cited as the ‘Lyme and Tick-Borne Disease Prevention, Education, and Research Act of 2009’.CommentsClose CommentsPermalink

SEC. 2. FINDINGS.

Congress makes the following findings:CommentsClose CommentsPermalink





(1) Lyme disease is a common but frequently misunderstood illness that, if not caught early and treated properly, can cause serious health problems.CommentsClose CommentsPermalink





(2) Lyme disease is caused by the bacterium Borrelia burgdorferi, which belongs to the class of spirochetes, and is transmitted to humans by the bite of infected black-legged ticks. Early signs of infection may include a rash and flu-like symptoms such as fever, muscle aches, headaches, and fatigue.CommentsClose CommentsPermalink





(3) Although Lyme disease can be treated with antibiotics if caught early, the disease often goes undetected because it mimics other illnesses or may be misdiagnosed. Untreated, Lyme disease can lead to severe heart, neurological, eye, and joint problems because the bacteria can affect many different organs and organ systems.CommentsClose CommentsPermalink





(4) If an individual with Lyme disease does not receive treatment, such individual can develop severe heart, neurological, eye, and joint problems.CommentsClose CommentsPermalink





(5) Although Lyme disease accounts for 90 percent of all vector-borne infections in the United States, the ticks that spread Lyme disease also spread other diseases, such as anaplasmosis, babesiosis, and tularemia, and carry Bartonella and other strains of Borrelia. Other tick species, such as the aggressive lone star, spread ehrlichiosis, Rocky Mountain spotted fever, and southern tick-associated rash illness (STARI). Multiple diseases in 1 patient make diagnosis and treatment more difficult.CommentsClose CommentsPermalink





(6) The Centers for Disease Control and Prevention reported 27,444 new cases of Lyme disease in 2007, a 38 percent increase nationally from 2006. Studies indicate that the actual number of tick-borne disease cases is approximately 10 times the amount reported.CommentsClose CommentsPermalink





(7) According to the Centers for Disease Control and Prevention, from 1992 to 2006, the incidence of Lyme disease was highest among children aged 5 to 14 years of age.CommentsClose CommentsPermalink





(8) Persistence of symptomatology in many patients without reliable testing makes treatment of patients more difficult.CommentsClose CommentsPermalink

SEC. 3. ESTABLISHMENT OF A TICK-BORNE DISEASES ADVISORY COMMITTEE.

(a) Establishment- Not later than 180 days after the date of the enactment of this Act, the Secretary of Health and Human Services (referred to in this Act as the ‘Secretary’) shall establish within the Office of the Secretary an advisory committee to be known as the Tick-Borne Diseases Advisory Committee (referred to in this section as the ‘Committee’).CommentsClose CommentsPermalink





(b) Duties- The Committee shall advise the Secretary and the Assistant Secretary for Health regarding the manner in which such officials can--CommentsClose CommentsPermalink





(1) ensure interagency coordination and communication and minimize overlap regarding efforts to address tick-borne diseases;CommentsClose CommentsPermalink





(2) identify opportunities to coordinate efforts with other Federal agencies and private organizations addressing such diseases;CommentsClose CommentsPermalink





(3) ensure interagency coordination and communication with constituency groups;CommentsClose CommentsPermalink





(4) ensure that a broad spectrum of scientific viewpoints are represented in public health policy decisions and that information disseminated to the public and physicians is balanced; andCommentsClose CommentsPermalink





(5) advise relevant Federal agencies on priorities related to Lyme and other tick-borne diseases.CommentsClose CommentsPermalink





(c) Membership-CommentsClose CommentsPermalink





(1) APPOINTED MEMBERS-CommentsClose CommentsPermalink





(A) IN GENERAL- From among individuals who are not officers or employees of the Federal Government, the Secretary shall appoint to the Committee, as voting members, the following:CommentsClose CommentsPermalink





(i) Not less than 4 members from the scientific community representing the broad spectrum of viewpoints held within the scientific community related to Lyme and other tick-borne diseases.CommentsClose CommentsPermalink





(ii) Not less than 2 representatives of tick-borne disease voluntary organizations.CommentsClose CommentsPermalink





(iii) Not less than 2 health care providers, including not less than 1 full-time practicing physician, with relevant experience providing care for individuals with a broad range of acute and chronic tick-borne diseases.CommentsClose CommentsPermalink





(iv) Not less than 2 patient representatives who are individuals who have been diagnosed with a tick-borne disease or who have had an immediate family member diagnosed with such a disease.CommentsClose CommentsPermalink





(v) At least 2 representatives of State and local health departments and national organizations that represent State and local health professionals.CommentsClose CommentsPermalink





(B) DIVERSITY- In appointing members under this paragraph, the Secretary shall ensure that such members, as a group, represent a diversity of scientific perspectives relevant to the duties of the Committee.CommentsClose CommentsPermalink





(2) EX OFFICIO MEMBERS- The Secretary shall designate, as nonvoting, ex officio members of the Committee, representatives overseeing tick-borne disease activities from each of the following Federal agencies:CommentsClose CommentsPermalink





(A) The Centers for Disease Control and Prevention.CommentsClose CommentsPermalink





(B) The National Institutes of Health.CommentsClose CommentsPermalink





(C) The Agency for Healthcare Research and Quality.CommentsClose CommentsPermalink





(D) The Food and Drug Administration.CommentsClose CommentsPermalink





(E) The Office of the Assistant Secretary for Health.CommentsClose CommentsPermalink





(F) Such additional Federal agencies as the Secretary determines to be appropriate.CommentsClose CommentsPermalink





(3) CO-CHAIRPERSONS- The Secretary shall designate the Assistant Secretary of Health as the co-chairperson of the Committee. The appointed members of the Committee shall also elect a public co-chairperson. The public co-chairperson shall serve a 2-year term.CommentsClose CommentsPermalink





(4) TERM OF APPOINTMENT- The term of service for each member of the Committee appointed under paragraph (1) shall be 4 years.CommentsClose CommentsPermalink





(5) VACANCY- A vacancy in the membership of the Committee shall be filled in the same manner as the original appointment. Any member appointed to fill a vacancy for an unexpired term shall be appointed for the remainder of that term. Members may serve after the expiration of their terms until their successors have taken office.CommentsClose CommentsPermalink





(d) Meetings- The Committee shall hold public meetings, except as otherwise determined by the Secretary, after providing notice to the public of such meetings, and shall meet at least twice a year with additional meetings subject to the call of the co-chairpersons. Agenda items with respect to such meetings may be added at the request of the members of the Committee, including the co-chairpersons. Meetings shall be conducted, and records of the proceedings shall be maintained, as required by applicable law and by regulations of the Secretary.CommentsClose CommentsPermalink





(e) Report- Not later than 1 year after the date of enactment of this Act, and annually thereafter, the Committee, acting through the members representing the Centers for Disease Control and Prevention and the National Institutes of Health, shall submit a report to the Secretary. Each such report shall contain, at a minimum--CommentsClose CommentsPermalink





(1) a description of the Committee’s functions;CommentsClose CommentsPermalink





(2) a list of the Committee’s members and their affiliations; andCommentsClose CommentsPermalink





(3) a summary of the Committee’s activities and recommendations during the previous year, including any significant issues regarding the functioning of the Committee.CommentsClose CommentsPermalink





(f) Authorization of Appropriations- For the purpose of carrying out this section, there is authorized to be appropriated $250,000 for each of the fiscal years 2010 through 2014. Amounts appropriated under the preceding sentence shall be used for the expenses and per diem costs incurred by the Committee under this section in accordance with the Federal Advisory Committee Act (5 U.S.C. App.), except that no voting member of the Committee shall be a permanent salaried employee.CommentsClose CommentsPermalink

SEC. 4. FEDERAL ACTIVITIES RELATED TO THE DIAGNOSIS, SURVEILLANCE, PREVENTION, AND RESEARCH OF LYME AND OTHER TICK-BORNE DISEASES.

(a) In General- The Secretary, acting as appropriate through the Director of the Centers for Disease Control and Prevention, the Director of the National Institutes of Health, the Commissioner of Food and Drugs, and the Director of the Agency for Healthcare Research and Quality, as well as additional Federal agencies as the Secretary determines to be appropriate, and in consultation with the Tick-Borne Diseases Advisory Committee, shall provide for--CommentsClose CommentsPermalink





(1) the conduct or support of the activities described in subsection (b); andCommentsClose CommentsPermalink





(2) the coordination of all Federal programs and activities related to Lyme disease and other tick-borne diseases.CommentsClose CommentsPermalink





(b) Activities- The activities described in this subsection are the following:CommentsClose CommentsPermalink





(1) DEVELOPMENT OF DIAGNOSTIC TESTS- Such activities include--CommentsClose CommentsPermalink





(A) the development of sensitive and more accurate diagnostic tools and tests, including a direct detection test for Lyme disease capable of distinguishing active infection from past infection;CommentsClose CommentsPermalink





(B) improving the efficient utilization of diagnostic testing currently available to account for the multiple clinical manifestations of both acute and chronic Lyme disease; andCommentsClose CommentsPermalink





(C) providing for the timely evaluation of promising emerging diagnostic methods.CommentsClose CommentsPermalink





(2) SURVEILLANCE AND REPORTING- Such activities include surveillance and reporting of Lyme and other tick-borne diseases--CommentsClose CommentsPermalink





(A) to accurately determine the prevalence of Lyme and other tick-borne diseases;CommentsClose CommentsPermalink





(B) to evaluate the feasibility of developing a reporting system for the collection of data on physician-diagnosed cases of Lyme disease that do not meet the surveillance criteria of the Centers for Disease Control and Prevention in order to more accurately gauge disease incidence; andCommentsClose CommentsPermalink





(C) to evaluate the feasibility of creating a national uniform reporting system including required reporting by laboratories in each State.CommentsClose CommentsPermalink





(3) PREVENTION- Such activities include--CommentsClose CommentsPermalink





(A) the provision and promotion of access to a comprehensive, up-to-date clearinghouse of peer-reviewed information on Lyme and other tick-borne diseases;CommentsClose CommentsPermalink





(B) increased public education related to Lyme and other tick-borne diseases through the expansion of the Community Based Education Programs of the Centers for Disease Control and Prevention to include expansion of information access points to the public;CommentsClose CommentsPermalink





(C) the creation of a physician education program that includes the full spectrum of scientific research related to Lyme and other tick-borne diseases; andCommentsClose CommentsPermalink





(D) the sponsoring of scientific conferences on Lyme and other tick-borne diseases, including reporting and consideration of the full spectrum of clinically based knowledge, with the first of such conferences to be held not later than 24 months after the date of enactment of this Act.CommentsClose CommentsPermalink





(4) CLINICAL OUTCOMES RESEARCH- Such activities include--CommentsClose CommentsPermalink





(A) the establishment of epidemiological research objectives to determine the long term course of illness for Lyme disease; andCommentsClose CommentsPermalink





(B) determination of the effectiveness of different treatment modalities by establishing treatment outcome objectives.CommentsClose CommentsPermalink





(c) Authorization of Appropriations-CommentsClose CommentsPermalink





(1) IN GENERAL- For the purposes of carrying out this section, and for the purposes of providing for additional research, prevention, and educational activities for Lyme and other tick-borne diseases, there is authorized to be appropriated $20,000,000 for each of the fiscal years 2010 through 2014.CommentsClose CommentsPermalink





(2) CDC ACTIVITIES- Of the amounts authorized to be appropriated under paragraph (1)--CommentsClose CommentsPermalink





(A) for fiscal year 2010, not less than $7,500,000 shall be for activities of the Centers for Disease Control and Prevention that support the purposes described in such paragraph; andCommentsClose CommentsPermalink





(B) for each of fiscal years 2011 through 2014, not less than $5,000,000 shall be for such activities of the Centers for Disease Control and Prevention.CommentsClose CommentsPermalink





(3) ADDITIONAL AMOUNTS- The authorization of appropriations under this subsection is in addition to any other authorization of appropriations available for the purposes described in paragraph (1).CommentsClose CommentsPermalink

SEC. 5. REPORTS ON LYME AND OTHER TICK-BORNE DISEASES.

(a) In General- Not later than 18 months after the date of enactment of this Act, and annually thereafter, the Secretary shall submit to Congress a report on the activities carried out under this Act.CommentsClose CommentsPermalink





(b) Content- Reports under subsection (a) shall contain--CommentsClose CommentsPermalink





(1) significant activities or developments related to the surveillance, diagnosis, treatment, education, or prevention of Lyme or other tick-borne diseases, including suggestions for further research and education;CommentsClose CommentsPermalink





(2) a scientifically qualified assessment of Lyme and other tick-borne diseases, including both acute and chronic instances, related to the broad spectrum of empirical evidence of treating physicians, as well as published peer reviewed data, that shall include recommendations for addressing research gaps in diagnosis and treatment of Lyme and other tick-borne diseases and an evaluation of treatment guidelines and their utilization;CommentsClose CommentsPermalink





(3) progress in the development of accurate diagnostic tools that are more useful in the clinical setting for both acute and chronic disease;CommentsClose CommentsPermalink





(4) the promotion of public awareness and physician education initiatives to improve the knowledge of health care providers and the public regarding clinical and surveillance practices for Lyme disease and other tick-borne diseases; andCommentsClose CommentsPermalink





(5) a copy of the most recent annual report issued by the Tick-Borne Diseases Advisory Committee established under section 3 and an assessment of progress in achieving the recommendations included in the Committee’s report.CommentsClose CommentsPermalink